1st Quarter - Termination
C2 GROUP, LLC for PERRIGO INC
Firm
Client
Income
$50,000
Expenses
—
Terminated
Mar 15, 2013
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS CRAWFORD | — |
| JEFFERIES MURRAY | — |
| GALEN J RESER | — |
| DAVID PATRICK ROBERTSON | — |
Taxation/Internal Revenue Code TAX
Monitor tax reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS CRAWFORD | — |
| GALEN J RESER | — |
| DAVID PATRICK ROBERTSON | — |
Health Issues HCR
Dextromethorphan, Pseudoephedrine restriction issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS CRAWFORD | — |
| GALEN J RESER | — |
| DAVID PATRICK ROBERTSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.